News

Semaglutide injections reversed some cases of MASH liver disease in clinical trials, reducing inflammation in 62.9% of ...
Since its historic FDA approval in March 2024 as the first medication for the treatment of the prevalent liver disease ...
So, there's this scientist, Arun Sanyal, M.D., who's the director of the VCU Stravitz-Sanyal Institute for Liver Disease and ...
Semaglutide is the key component of weight loss and diabetes drugs like Ozempic and Wegovy, and an international team of ...